Joint Pain

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Bioiberica
BioibericaSpain - Barcelona
1 program
Native type II collagenN/A1 trial
Active Trials
NCT05282992Completed75Est. Mar 2024

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
BioibericaNative type II collagen

Clinical Trials (1)

Total enrollment: 75 patients across 1 trials

NCT05282992BioibericaNative type II collagen

NAtive Collagen Type II In Healthy VoluntEers With Joint Discomfort

Start: Mar 2022Est. completion: Mar 202475 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space